https://www.selleckchem.com/pr....oducts/1-thioglycero
gue scale scores resulted in significant differences between patients who developed hypophosphatemia or not. Fibroblast growth factor 23 has a key role in FCM induced hypophosphatemia, probably by inducing loss of phosphate in the urine. Short-term clinical impact of hypophosphatemia was not demonstrated. Fibroblast growth factor 23 has a key role in FCM induced hypophosphatemia, probably by inducing loss of phosphate in the urine. Short-term clinical impact of hypophosphatemia was not demonstrated. Antiviral therapy cannot compl
Like
Comment
Share
